Restorative effect of atrial natriuretic peptide or chronic neutral endopeptidase inhibition on blunted cardiopulmonary vagal reflexes in aged rats

Hypertension

Volumn 52, Issue 4, 2008, Pages 696-701

  Thomas, Colleen J ^a   McAllen, Robin M ^a   Salo, Lauren M ^a   Woods, Robyn L ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Aged; Autonomic; Cardiac; Ischemia; Sensory afferent

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CANDOXATRILAT; MEMBRANE METALLOENDOPEPTIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRADYCARDIA; CONTROLLED STUDY; HEART RATE; MALE; NONHUMAN; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; RAT; VAGUS NERVE STIMULATION; VAGUS REFLEX; AGING; ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; FOLLOW UP; HEART ATRIUM; HEART VENTRICLE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOIMMUNOASSAY; SIGNAL TRANSDUCTION; VAGUS NERVE; WISTAR RAT;

AGING; ANIMALS; ATRIAL NATRIURETIC FACTOR; BAROREFLEX; BRADYCARDIA; DISEASE MODELS, ANIMAL; FOLLOW-UP STUDIES; HEART ATRIA; HEART VENTRICLES; INFUSIONS, INTRAVENOUS; MALE; NEPRILYSIN; RADIOIMMUNOASSAY; RATS; RATS, WISTAR; SIGNAL TRANSDUCTION; VAGUS NERVE;

EID: 54749156035     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.108.111302     Document Type: Article

References (38)

1. Mancia G, Cleroux J, Daffonchio A, Ferrari AU, Giannattasio C, Grassi G. Reflex control of circulation in the elderly. Cardiovasc Drugs Ther. 1990;4(suppl 6):1223-1228.
2. Ferrari AU, Radaelli A, Centola M. Invited review: aging and the cardiovascular system. J Appl Physiol. 2003;95:2591-2597.
3. Cleroux J, Giannattasio C, Bolla G, Cuspidi C, Grassi G, Mazzola C, Sampieri L, Seravalle G, Valsecchi M, Mancia G. Decreased cardiopulmonary reflexes with aging in normotensive humans. Am J Physiol. 1989;257:H961-H968.
4. Ferrari AU. Modifications of the cardiovascular system with aging. Am J Geratr Cardiol. 2002;11:30-33.
5. Hainsworth R. Sensory functions of the heart. Ann Acad Med Singapore. 1994;23:546-551.
6. Davidow LW, Schmitz TM, Bunag RD. Aging enhances serotonergic cardiovascular blockade by ketanserin in conscious rats. Aging (Milano). 1994;6:239-248.
7. Sakima A, Averill DB, Gallagher PE, Kasper SO, Tommasi EN, Ferrario CM, Diz DI. Impaired heart rate baroreflex in older rats: role of endogenous angiotensin-(1-7) at the nucleus tractus solitarii. Hypertension. 2005;46:333-340.
8. Townend JN, Littler WA. Cardiac vagal activity: a target for intervention in heart disease. Lancet. 1995;345:937-938.
9. Thomas CJ, Rankin AJ, Head GA, Woods RL. ANP enhances bradycardic reflexes in normotensive but not spontaneously hypertensive rats. Hypertension. 1997;29:1126-1132.
10. Thomas CJ, May CN, Sharma AD, Woods RL. ANP, BNP, and CNP enhance bradycardic responses to cardiopulmonary chemoreceptor activation in conscious sheep. Am J Physiol. 2001;280:R282-R288.
11. Thomas CJ, Head GA, Woods RL. Similar baroreflex bradycardic actions of atrial natriuretic peptide and B and C types of natriuretic peptides in conscious rats. J Hypertens. 1999;17:801-806.
12. Thomas CJ, Allen AM, McAllen RM, Woods RL. ANP potentiates nonarterial baroreflex bradycardia: evidence from sinoaortic denervation in rats. Auton Neurosci. 2002;97:89-98.
13. Fitzpatrick MA, Rademaker MT, Charles CJ, Yandle TG, Espiner EA, Ikram H, Sybertz E. Acute hemodynamic, hormonal, and renal effects of neutral endopeptidase inhibition in ovine heart failure. J Cardiovasc Pharmacol. 1992;19:635-640.
14. McDowell G, Coutie W, Shaw C, Buchanan KD, Struthers AD, Nicholls DP. The effect of the neutral endopeptidase inhibitor drug, candoxatril, on circulating levels of two of the most potent vasoactive peptides. Br J Clin Pharmacol. 1997;43:329-332.
15. O'Connell JE, Jardine AG, Davidson G, Connell JM. Candoxatril, an orally active neutral endopeptidase inhibitor, raises plasma atrial natriuretic factor and is natriuretic in essential hypertension. J Hypertens. 1992;10:271-277.
16. Northridge DB, Currie PF, Newby DE, McMurray JJ, Ford M, Boon NA, Dargie HJ. Placebo-controlled comparison of candoxatril, an orally active neutral endopeptidase inhibitor, and captopril in patients with chronic heart failure. Eur J Heart Fail. 1999;1:67-72.
17. Yoshida K, Masayuki K, Casley DJ, Katopothis A, Johnston CI. Inhibition of kidney neutral endopeptidase after administration of the neutral endopeptidase inhibitor Candoxatril: quantitation by autoradiography. J Card Pharmacol. 1998;32:702-708.
18. Woods RL, Courneya CA, Head GA. Nonuniform enhancement of baroreflex sensitivity by atrial natriuretic peptide in conscious rats and dogs. Am J Physiol. 1994;267:R678-R686.
19. Thomas CJ, Woods RL. Guanylyl cyclase receptors mediate cardiopulmonary vagal reflex actions of ANP. Hypertension. 2003;41:279-285.
20. Craft N, Schwartz JB. Effects of age on intrinsic heart rate, heart rate variability, and AV conduction in healthy humans. Am J Physiol. 1995;268:H1441-H1452.
21. Younes A, Boluyt MO, O'Neill L, Meredith AL, Crow MT, Lakatta EG. Age-associated increase in rat ventricular ANP gene expression correlates with cardiac hypertrophy. Am J Physiol. 1995;269:H1003-H1008.
22. Greenfeld Z, Engels K, Samsell L, Baylis C. Acute neutral endopeptidase inhibition is natriuretic in old rats. Mech Ageing Dev. 2001;122:1293-1301.
23. O'Mahony D, Bennett C, Green A, Sinclair AJ. Reduced baroreflex sensitivity in elderly humans is not due to efferent autonomic dysfunction. Clin Sci. 2000;98:103-110.
24. Ferrari AU, Daffonchio A, Gerosa S, Mancia G. Alterations in cardiac sympathetic function in aged rats. Am J Physiol. 1991;260:H647-H649.
25. Chapleau MW, Cunningham JT, Sullivan MJ, Wachtel RE, Abboud FM. Structural versus functional modulation of the arterial baroreflex. Hypertension. 1995;26:341-347.
26. Imura H, Nakao K, Itoh H. The natriuretic peptide system in the brain: implications in the central control of cardiovascular and neuroendocrine functions. From Neuroendocrinol. 1992;13:217-249.
27. Atchison DJ, Ackermann U. Influence of atrial natriuretic factor on autonomic control of heart rate. Am J Physiol. 1990;258:R718-R723.
28. Toader E, McAllen RM, Cividjian A, Woods RL, Quintin L. Effect of systemic B-type natriuretic peptide on cardiac vagal motorneuron activity. Am J Physiol. 2007;293:H3465-H3470.
29. Wu SQ, Kwan CY, Tang F. The effect of aging on ANP levels in the plasma, heart, and brain of rats. J Gerontol A Biol Sci Med Sci. 1997;52:B250-B254.
30. Kato J, Kitamura K, Uemura T, Kuwasako K, Kita T, Kangawa K, Eto T. Plasma levels of adrenomedullin and atrial and brain natriuretic peptides in the general population: their relations to age and pulse pressure. Hypertens Res. 2002;25:887-892.
31. Tan AC, Jansen TL, Termond EF, Russel FG, Thien T, Kloppenborg PW, Benraad TJ. Kinetics of atrial natriuretic peptide in young and elderly subjects. Eur J Clin Pharmacol. 1992;42:449-452.
32. Rademaker MT, Fitzpatrick MA, Charles CJ, Richards AM, Nicholls MG, Espiner EA, Sybertz E. Comparison of chronic neutral endopeptidase inhibition and furosemide in an ovine model of heart failure. J Cardiovasc Pharmacol. 1996;27:439-446.
33. Kentsch M, Otter W, Drummer C, Notges A, Gerzer R, Muller-Esch G. Neutral endopeptidase 24.11 inhibition may not exhibit beneficial haemodynamic effects in patients with congestive heart failure. Eur J Clin Pharmacol. 1996;51:269-272.
34. Lisy O, Jougasaki M, Schirger JA, Chen HH, Barclay PT, Burnett JC Jr. Neutral endopeptidase inhibition potentiates the natriuretic actions of adrenomedullin. Am J Physiol. 1998;275:F410-F414.
35. Roques BP, Noble F, Dauge V, Fournie-Zaluski MC, Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol Rev. 1993;45:87-146.
36. Vijayaraghavan J, Scicli AG, Carretero OA, Slaughter C, Moomaw C, Hersh LB. The hydrolysis of endomelins by neutral endopeptidase 24.11 (enkephalinase). J Biol Chem. 1990;265:14150-14155.
37. Schultz HD, Wang W, Ustinova EE, Zucker IH. Enhanced responsiveness of cardiac vagal chemosensitive endings to bradykinin in heart failure. Am J Physiol. 1997;273:R637-R645.
38. Malinowska B, Godlewski G, Buczko W, Gothert M. Facilitation by substance P and inhibition by (+)-tubocurarine of the 5-HT3 receptor-mediated Bezold-Jarisch reflex in rats. Eur J Pharmacol. 1996;315:159-164.